drugset / Trial / NCT00652925

A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA

NCT00652925

Phase 3 Completed 225 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To study Celebrex versus naproxen to see if it decreases symptoms of juvenile arthritis such as pain and swelling.

Timeline

Start
2002-10
Primary completion
2004-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 6 mg/kg
Comparator Naproxen Small molecule 15 mg/kg